检查点CD24对瘤和免疫治疗的功能
Shiming Huang1,2,3, Xiaobo Zhang1, Yingtian Wei1
1Department of Radiology, First Medical Center, Chinese People's Liberation Army General Hospital, Beijing, China.
Frontiers in immunology
|March 15, 2024
概括
癌细胞上的CD24蛋白有助于瘤通过与Siglec-10相互作用来逃避免疫攻击. 向CD24对癌症免疫治疗有希望,通过安全有效的临床试验.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- CD24是一种细胞表面蛋白质,对癌细胞的增殖,入侵和转移至关重要.
- CD24与免疫细胞上的Siglec-10相互作用,抑制自然杀手细胞和巨细胞的功能.
- 这种相互作用使瘤细胞能够逃避免疫监测和破坏.
研究的目的:
- 审查CD24在免疫系统和癌症进展中的作用.
- 评估CD24作为癌症免疫治疗的潜在免疫检查点目标.
- 总结针对CD24的当前和新兴治疗策略.
主要方法:
- 关于CD24的临床前和临床研究的文献综述.
- 分析CD24与Siglec-10的相互作用及其对抗瘤免疫力的影响.
- 检查治疗方法,包括单克隆抗体,CAR T细胞和基因疗法.
主要成果:
- CD24-Siglec-10的相互作用抑制了抗瘤免疫反应.
- 针对CD24的单克隆抗体在临床试验中耐受性良好且安全.
- 临床前研究表明了CAR T细胞,抗体-药物合物和基因疗法的潜力.
结论:
- CD24是癌症免疫逃避的重要媒介.
- CD24代表了一种有希望的免疫检查点目标,用于新的癌症免疫疗法.
- 进一步的研究和CD24向疗法的临床开发是有必要的.
相关概念视频
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K